A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT

Patil, Shivaprasad; Linge, Annett; Hiepe, Hannah; Grosser, Marianne; Lohaus, Fabian; Gudziol, Volker; Kemper, Max; Nowak, Alexander; Haim, Dominik; Tinhofer, Inge; Budach, Volker; Guberina, Maja; Stuschke, Martin; Balermpas, Panagiotis; von Der Grun, Jens; Schafer, Henning; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jurgen; Ganswindt, Ute; Belka, Claus; Pigorsch, Steffi; Combs, Stephanie E.; Boeke, Simon; Zips, Daniel; Johrens, Korinna; Baretton, Gustavo B.; Baumann, Michael; Krause, Mechthild; Lock, Steffen

A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT

Autor(en):

Patil, Shivaprasad; Linge, Annett; Hiepe, Hannah; Grosser, Marianne; Lohaus, Fabian; Gudziol, Volker; Kemper, Max; Nowak, Alexander; Haim, Dominik; Tinhofer, Inge; Budach, Volker; Guberina, Maja; Stuschke, Martin; Balermpas, Panagiotis; von Der Grun, Jens; Schafer, Henning; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jurgen; Ganswindt, Ute; Belka, Claus; Pigorsch, Steffi; Combs, Stephanie E.; Boeke, Simon; Zips, Daniel; Johrens, Korinna; Baretton, Gustavo B.; Baumann, Michael; Krause, Mechthild; Lock, Steffen

Tübinger Autor(en):

Gudziol, Volker
Zips, Daniel
Böke, Simon

Erschienen in:

Cancers (2022), Bd. 14 (12), Article 3031

Verlagsangabe:

Mdpi

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.3390/cancers14123031

ISSN:

2072-6694